Health Catalyst (HCAT) Q3 Earnings Miss Estimates
Portfolio Pulse from
Health Catalyst (HCAT) reported Q3 earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This is an improvement from $0.03 per share a year ago.
November 06, 2024 | 11:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Health Catalyst reported Q3 earnings of $0.07 per share, missing the expected $0.10. Despite the miss, earnings improved from $0.03 a year ago.
The earnings miss is likely to negatively impact HCAT's stock price in the short term as it failed to meet analyst expectations. However, the improvement from last year's earnings may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100